News Centermore
-
Athenex Announces FDA Allowance of Investigational New Drug Application of Eribulin ORA to Begin Clinical Trials.
Oct 30, 2018
-
“Evolution of LAPSCOVERY”…Apply to diabetes, obesity, NASH and rare disease.
Oct 10, 2018
-
Sanofi to begin additional global phase 3 clinical trial of hanmi's new obesity and diabetes drug 'Efpeglenatide'
Oct 05, 2018
-
Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients.
Sep 27, 2018
-
Athenex Announces Positive Recommendation by the Drug Safety Monitoring Board Upon the Second Interim Analysis and to Continue the Oraxol Phase III Program.
Sep 07, 2018
AMOSARTAN TAB.5/50mg
Esomezol cap.
PalPal tab.
Pidogul tab.
Fluterol inhalation powder
Hyalrheuma Inj.
Triaxone inj.
Muco Gard